Supplement: Turning Tobacco into Therapies

Turning Tobacco into Therapies By Jeffrey M. Perkel RELATED ARTICLES Innovative Technology Daniel Skovronsky: Scientist and leader Biofuel: The Potential Magic Bullet Britton Chance: Still searching for answers Art Caplan: Penn's renowned ethicist Technology Roundup The Delaware Technology Park in Newark just may be the site of the next revolution. There, in a two-story building aptly named "9 Innovation Way," the Fraunhofer USA Center for Mo

Written byJeffrey M. Perkel
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Innovative Technology

Daniel Skovronsky: Scientist and leader

Biofuel: The Potential Magic Bullet

Britton Chance: Still searching for answers

Art Caplan: Penn's renowned ethicist

Technology Roundup

The Delaware Technology Park in Newark just may be the site of the next revolution. There, in a two-story building aptly named "9 Innovation Way," the Fraunhofer USA Center for Molecular Biotechnology (CMB) is putting a sort of molecular spin on the age-old ideal of turning swords into plowshares.

In a development that could fundamentally redefine the technology of vaccine production, Fraunhofer's scientists are turning tobacco plants from weapons of mass addiction into medical tools. The center has devised a way to use the plants as chlorophyll-fueled factories dedicated to the manufacture of vaccine antigens, therapeutic proteins, and the like.

CMB calls its core technology "molecular farming" - genetic manipulation of plants with viral RNAs engineered to express a particular antigen in infected plant ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies